Associated Partner

Center for Personalized Cancer Treatment hosted by Radboud University Medical Center

Nijmegen,

Netherlands

The orignal DRUP-trial was launched in 2016 by the Center for Personalized Cancer Treatment (CPCT). CPCT is hosted by the Radboud University Medical Center, a university medical center for patient care, research and education, located in Nijmegen, The Netherlands. The CPCT managing team consists of five PIs located at four Dutch institutions: Radboud University Medical Center, Netherlands Cancer Institute, Erasmus MC and Leiden University Medical Center.

CPCT will in PRIME-ROSE be involved in WP 1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Key People Involved:

Professor Haiko Bloemendal

MD, PhD, Medical Oncologist, Radboud University

Professor Emile Voest

MD, PhD, Director Cancer Core Europe and Professor and Medical Oncologist, The Netherlands Cancer Institute

Professor Henk Verheul

MD, PhD, Head Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam

Professor Hans Gelderblom

MD, PhD, Head Dept. of Medical Oncology, Leiden University Medical Centre

Professor Egbert Smit

MD, PhD, Leiden University Medical Centre

partners

Beneficiaries & Associated Partners

Beneficiary

Region Uppsala

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Beneficiary

Stockholm School of Economics Institute for Research (SIR)

Work package leader social innovation (WP6).

Beneficiary

Leiden University Medical Center (LUMC)

Work package leader data aggregation (WP1) and early access & drup repurposing (WP4). Will in addition co-coordinate the project (WP7) and contribute to WP3 (expansion cohorts and WP6 (social innovation).